Nico.lab Pre IPO, page-504

I'm a bit more optimistic than you guys. After lengthy delays we now have the people and systems in place to sign up hospitals. The forecast of 120 this FY is conservative, and I think the next update will show we already have in excess of this. I'm more interested in the 23 forecast to check on my above valuation assumptions. We are earning US & EU which is healthy against the AUD. From the prior update there was a large sales opportunity of ~ 40 hospitals we were targeting. Fingers crossed we were successful.

Our competitor, Viz.Ai, raised recently at US$1.2b. (AU$1.8 b) While they have first mover advantage and healthier revenue, we have a superior product, better data, and are backed by Philips.

Viz $1.2b raise

The AGM and prior shareholder update indicated we have cash until mid 23+. Yes, they could raise earlier to expedite growth rates.